Accueil Ernstrade Bourse Actualite Stock

 


Polydex Pharmaceuticals Limited (USA),
Nasdaq

Polydex Pharmaceuticals Limited is engaged in the research, development, manufacture and marketing of biotechnology-based products for the human pharmaceutical market. The Company also manufactures bulk pharmaceutical intermediates for the global veterinary pharmaceutical industry. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Dextran, a generic name applied to certain synthetic compounds formed by bacterial growth on sucrose, is a polymer or giant molecule. The products of the Company include Iron Dextran and Dextran Sulphate. The wholly owned subsidiaries of the Company include Dextran Products Limited (Dextran Products) and Chemdex Inc (Chemdex). 

http://www.polydex.com/
Address
421 Comstock Road
Toronto, ON M1L 2H5
Canada
+1-416-7552231 (Phone)
+1-416-7550334 (Fax)
 
 
 
 
 
 
 
 
 
 
 

 


 
 
 
 
 

Copyright  2011  Ernstrade

Avertissement légal - Contact Webmaster - Partenaires